Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies
Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies have?
Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies has 52 citations in the OpenAlex counts ScholarIQ stores.
When was Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies published?
Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies has 2014 year in the ScholarIQ index.
What is the open-access status of Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies?
Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies has closed oa status in the ScholarIQ index.
What is the DOI of Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies?
The DOI for Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies is on the source record.
What is the PMID of Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies?
The PMID for Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies is on the source record.
What is the OpenAlex record for Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies?
The OpenAlex for Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies is on the source record.